Long-term open-label safety study of rizatriptan acute treatment in pediatric migraineurs.


OBJECTIVE To evaluate the safety/tolerability of rizatriptan in the long-term acute treatment of migraine in pediatric patients. BACKGROUND Acute migraine treatment options for children are limited. A recent single-attack trial demonstrated that rizatriptan is effective in eliminating migraine headache pain in this population. We evaluated the long-term… (More)
DOI: 10.1111/j.1526-4610.2012.02285.x

5 Figures and Tables


  • Presentations referencing similar topics